THE MUSCLE GLYCOGEN SYNTHESIS PATHWAY plays a central role in whole body glucose homeostasis. The flux through this pathway is acutely activated by insulin after a glucose load, allowing increased uptake of plasma glucose. Under the conditions of a hyperinsulinemic hyperglycemic clamp, muscle glycogen synthesis accounts for the majority of whole body glucose uptake in humans (29) . Impaired glycogen synthesis accounts for the deficit of glucose storage in patients with non-insulin-dependent diabetes mellitus under these conditions (29) . Glucose is transported into the cell by facilitative diffusion mediated by membrane glucose transporters (GT). Hexokinase (Hk) phosphorylates the C-6 position of glucose. Glucose 6-phosphate (G-6-P) is isomerized and activated to UDP-glucose, which is incorporated by glycogen synthase (GSase) into the glycogen polymer. The activities of GT (14, 20, 37) , GSase (7, 8, 21) , and possibly Hk (18) are regulated by insulin levels. Both GSase and Hk are under allosteric regulation by G-6-P.
The coordinate regulation of the activity of several enzymes in this pathway by insulin has complicated efforts to assign a conventional rate-limiting step for glycogen synthesis. Correlations between the rates of GT and of glycogen synthesis or muscle glucose uptake have been interpreted as supporting GT control in transgenic mice overexpressing GLUT-4 (9, 36) , in previously exercised mice overexpressing , in glucose-clamped rats (11) , and in the human forearm (4) . However, the conclusion of transport control appears to contradict the extensive studies establishing that the activity of GSase correlates with the rate of muscle glycogen synthesis (3, 8, 40) . The correlation between GSase activity and glycogen synthesis and the extensive regulation of GSase activity by phosphorylation have been the basis for the view of GSase as controlling the glycogen synthesis flux.
A limitation of previous studies of the muscle glycogen synthesis pathway is that they have not quantitatively assessed metabolic control. In the last 25 years, metabolic control analysis (MCA) has provided a theoretical framework for quantitatively calculating from experimental data the control exerted by enzymes over the flux through a metabolic pathway (12, 16) . In MCA, the control an enzyme (E) exerts over a metabolic flux (J) is given by the flux control coefficient, C E J , which is defined as the fractional change in the flux through the pathway (␦J/J) when the activity of the enzyme is changed by a fraction ␦E/E C E J ϭ ͑␦J/J͒/͑␦E/E͒
Measurement of the flux control coefficient of an enzyme depends on selectively altering the activity of the enzyme while maintaining constant activities of other enzymes in the pathway. 1 Although these conditions cannot always be met experimentally, MCA has been applied successfully to determine flux control coefficients in a number of systems (12) .
Recently, we have used MCA to reanalyze a study we performed using 13 C and 31 P NMR to measure insulinstimulated muscle glycogen synthesis and G-6-P concentration in the muscle of healthy nondiabetic humans (26, 31) . The analysis indicated that the activity of the combined steps of GT and Hk (GT/Hk) determines the glycogen synthesis rate (31) . We proposed that the role of the insulin-dependent alteration of GSase activity by phosphorylation was to regulate the concentration of G-6-P rather than to determine the rate of the pathway (31). The results of several studies of human and rat muscle performed under hyperinsulinemic conditions were shown to be consistent with these conclusions. However, it was necessary to combine results from different studies to show that the conditions necessary to apply MCA were met.
The present in vivo NMR study was designed to allow calculation of the flux control coefficients of GT/Hk and GSase in the muscle glycogen synthesis pathway under hyperinsulinemic conditions in the rat. The synthesis rate of muscle glycogen was measured by 13 C NMR during a hyperinsulinemic clamp at two glucose concentrations to alter selectively the GT activity. 31 P NMR was used to verify that phosphorylated effectors of GSase other than G-6-P remained constant. The requirement for applying the analysis, that the phosphorylation state of GSase remain the same at both glucose levels, was established by direct assay. The application of MCA was extended from previous work (31) by incorporating the muscle glycolytic flux and using recently derived expressions that take into account the relatively large changes in plasma glucose concentration needed for the measurements (32, 33) . The results support the conclusion that, under euglycemic and/or hyperinsulinemic clamped conditions, the increase in insulin-induced GT/phosphorylation activity is the major control point for determining the rate of muscle glycogen synthesis, whereas GSase has little control over the glycogen synthesis flux.
MATERIALS AND METHODS
Protocol. The experimental protocol is shown schematically in Fig. 1 . Combined 13 C/ 31 P NMR spectra were acquired during the baseline period (t ϭ Ϫ50 min to t ϭ 0) and up to 180 min during a glucose/insulin clamp. A primed, continuous infusion of somatostatin at 0.1 g ⅐ kg Ϫ1 ⅐ min Ϫ1 (Bachem) and insulin at 10 mU ⅐ kg Ϫ1 ⅐ min Ϫ1 (Novolin) was begun at t ϭ 0 min. A primed, variable infusion of 20% wt/vol dextrose (100% [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]dextrose) was begun at t ϭ 0 min and adjusted to clamp the [glucose] plasma at ϳ5.5 mM (E; n ϭ 6) within 40 min. Euglycemic conditions were maintained for 50 min, during which time 13 C/ 31 P NMR spectra were acquired. At the end of this period, the infusion rate was adjusted to clamp the [glucose] plasma at ϳ13.9 mM [hyperglycemia (H); n ϭ 6]. After a 30-min period to allow the plasma glucose to stabilize, spectra were acquired under hyperglycemic conditions for 50 min. In one additional animal, the clamp order was reversed (H followed by E) as a control. At the end of the hyperglycemic clamp, the gastrocnemius was resected and the muscle frozen in liquid N 2 . The animals were euthanized by an intravenous dose of KCl. The muscles were stored at Ϫ70°C until assayed for [glycogen] or GSase activity.
An additional group of animals was studied outside the magnet with unlabeled glucose under conditions identical to the E or H phases described above (non-NMR groups: E, n ϭ 5; H, n ϭ 1). The gastrocnemius was removed after the clamp period for determination of GSase activity.
Animals. Overnight-fasted male Sprague-Dawley rats, 260-340 g, were anesthetized with 100 mg/kg Na ϩ /NaCO 3 thiopental. The rat was tracheotomized and ventilated on O 2 supplemented with room air. Catheters were inserted into the left jugular vein and right carotid artery for infusion and blood sampling, respectively. The skin over the calf and the knee was removed and the exposed muscle covered with plastic film. Brass pins were inserted under the patella and through the Achilles tendon, and the rat was fastened to a special Lucite holder for immobilization of the leg. For the NMR experiments, a coil was positioned directly over the exposed muscle. The animals were warmed throughout the experiment by means of a circulating water bath system. The animal protocol was approved by the Yale Animal Care and Use Committee.
Blood gases were monitored throughout on an ABL-30 analyzer (Radiometer, Copenhagen, Denmark), and the ventilation was adjusted to maintain O 2 at 90-120 mmHg and CO 2 at 35-45 mmHg.
[Glucose] plasma was determined in duplicate by the glucose oxidase method in a Glucose Analyzer II (Beckman, Fullerton, CA). Glucose consumption was calculated from the average steady-state glucose infusion rate.
[Insulin] was measured externally relative to human standards (VetResearch, White Plains, NY) from blood samples taken 10 min before the end of each clamp period.
NMR spectroscopy. NMR spectra were recorded on a 4.7 T horizontal bore Bruker Biospec spectrometer. The radio frequency probe consisted of two concentric coils: a 5-cm [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] Hz were obtained routinely. 13 C and 31 P spectra were acquired simultaneously in 11-min blocks, 13 C NMR acquisitions (TR ϭ 100 ms) interleaved 1 We define activity as the velocity of the enzyme under fixed conditions of substrate and allosteric effector concentration. In some cases this is proportional to enzyme concentration. 31 P NMR acquisitions (TR ϭ 4 s). For 13 C we used a 52-s, 180°hard pulse at the coil center; for 31 P we used a 90°B IR4 adiabatic pulse (2.5 ms duration). Glycogen 13 C-1 intensity was measured at 100.5 parts per million (ppm) in 40-Hz line-broadened spectra. For each block, 2,736 13 C and 72 31 P scans were obtained. The procedure for quantitating the concentration of G-6-P and other phosphorylated metabolites from the 31 P NMR spectra (see Fig. 2 ) was the same as that described in Bloch et al. (1), in which the method was validated against traditional chemical extraction. Levels of phosphorylated metabolites were determined from 31 P spectra summed over 40 min during baseline H and E periods (Fig. 2, inset) . The one-half area of the G-6-P peak (6.31 to 6.33 ppm relative to P i ) and the P i peak (0 to Ϫ1 ppm relative to P i ) were measured in the 10-Hz line-broadened baseline spectra, such as in Fig. 2 . The peaks correspond to phosphomonoesters (PME, including G-6-P) P i , phosphocreatine (PCr), ␥-ATP, ␣-ATP, and ␤-ATP. The concentration of metabolites was determined by comparing the spectral areas to the area of the ␤-ATP peak, for which the concentration is assumed to be 7.2 mM (1). Difference spectra were generated by subtracting the baseline from the E and H spectra, as shown in the inset in Fig. 2 . The [G-6-P] and [P i ] for E and H were determined by integrating the remainder of the peaks and comparing these to the ATP area. For total concentration during H and E, the difference is added to the baseline [G-6-P] and [P i ].
In vitro assays. Total [glycogen] was determined by amyloglucosidase digestion of precipitated glycogen. The [ 13 C]glucose enrichments of glucose in extracted glycogen and plasma were determined by gas chromatography-mass spectrometry, as described previously (2) . The fraction of GSase in the G-6-P-independent form (GSase%I) was assayed from the incorporation of [
14 C]glucose into glycogen by a modification of the method of Thomas (34) at 0 and 6.7 mM G-6-P, as described previously (2) . The GSase velocity in muscle homogenates was assayed enzymatically in a "physiological" mixture containing 8.4% glycogen, 0.1 mM UDPglucose (UDPG), 7.2 mM ATP, and 0, 0.2, 0.4, 0.8, and 1.2 mM G-6-P, corresponding to the in vivo range of [G-6-P].
Calculations. The [glycogen] at each time point was calculated as in Bloch et al. (2) from the increment in the 13 C spectra and the [1- 13 C]glucose enrichment. The synthesis rates reported for E and H were calculated from the slope of the linear regression of the glycogen concentrations over the 50 min of the clamp periods.
MCA. The MCA description of the glycogen synthesis pathway used to calculate the flux control coefficients is described in the APPENDIX. The responsivity coefficient at euglycemia was calculated from the change in glycogen synthesis rate in going from E to H by use of the following expression (32) , which takes into account the noninfinitesimal change in plasma glucose concentration
where J is the in vivo or in vitro glycogen synthesis flux, and G is the concentration of plasma glucose. The in vitro and in vivo elasticities of GSase to G-6-P were calculated using
where G-6-P is the concentration of glucose 6-phosphate. The elasticity of GT/Hk to G-6-P was calculated from the expression
The term J GT/Hk is total muscle glucose uptake, which is the sum of muscle glycogen synthesis and glycolysis. For calculations, whole body glucose uptake was used to approximate muscle glucose uptake. Under the experimental conditions of hyperinsulinemia, studies have shown that the muscle is the major pathway of disposal of infused glucose. All elasticity values were calculated with the group averages. A minimum estimate of the glycogen synthesis flux control coefficient for GT/Hk at euglycemia was calculated from the responsivity (30)
The relative glycogen synthesis flux control coefficients of GSase, GT/Hk, and glycolysis were calculated using the following expressions that are derived in the APPENDIX. The in vivo value for ⑀ G-6-P GSase was used in these calculations. Elasticities and control coefficient values were calculated for J glycolysis /J GT/Hk ranging from 0.14 to 0.50. This will maximize the estimate of C GSase J and minimize the estimate of C GT/Hk
All results are presented as means Ϯ SE. Statistical significance was calculated using a two-tailed Student's t-test for the paired data.
RESULTS
Glucose clamps. The concentrations of plasma glucose for individual animals during the E and H periods are shown in Table 1 . Plasma glucose concentration increased 2.5 Ϯ 0.03-fold, averaging 5.45 Ϯ 0.05 and 13.8 Ϯ 0.14 mM during the E and H clamps, respectively. The whole body glucose consumption increased to the same degree (2.8 Ϯ 0.3-fold) as the plasma glucose consumption, averaging 123 Ϯ 19 and 315 Ϯ 17 Glycogen synthesis. The animals varied in the starting [glycogen], ranging from 13.5 to 31.8 mmol/kg wet wt, with the average 21.0 Ϯ 2.5 mmol/kg wet wt. The total amount of glycogen synthesized during the experiment ranged from 15 to 41 mmol/kg wet wt. Individual curves of the increments in [glycogen] during the hyperinsulinemic clamp are shown in Fig. 3 . The synthesis rate averaged 0.087 Ϯ 0.012 and 0.24 Ϯ 0.03 mmol ⅐ kg Ϫ1 ⅐ min Ϫ1 (P Ͻ 0.01) during E and H, respectively. The rates of glycogen synthesis for individual animals are listed in Table 1 . Although the rates of glycogen synthesis varied between animals, the relative rates during the E and H periods were similar in all animals ( Table 1 ). The average glycogen synthesis rate increased in proportion with the [glucose] plasma (Fig. 4) .
Concentrations of phosphorylated effectors. To verify the constancy of phosphorylated effectors of GSase, the concentrations of ATP and P i were measured from different spectra under H and E conditions. The concentration of P i did not change with plasma glucose level (1.4 Ϯ 0.09 mM at E vs. 1.5 Ϯ 0.1 at H, NS, P Ͻ 0.4). The concentration of ATP, which was assumed to be 7.2 mM, remained constant throughout the study.
To assess the relative elasticities of GSase and GT/Hk to G-6-P, we measured the in vivo G-6-P concentration ( Table 2 ). The baseline G-6-P concentration was 0.18 Ϯ 0.02 mM. The G-6-P concentration did not increase significantly over baseline during the E portion of the clamp (0.22 Ϯ 0.03 mM, NS, P Ͻ 0.3). During the H portion of the clamp, the concentration of G-6-P increased by ⌬ ϭ 0.22 Ϯ 0.03 mM over baseline (P Ͻ 0.001). The increase in [G-6-P] was smaller than the increase in glycogen synthesis rate between E and H, as shown in Fig. 5 .
In vitro GSase%I and velocity as a function of [G-6-P].
To verify that the activity of GSase was not altered by the change in glucose concentration, the GSase%I was measured in vitro under standard conditions. No difference was found in GSase%I between E and H conditions (38 Ϯ 3 vs. 44 Ϯ 3%, NS, P Ͻ 0.2).
To assess the regulation of GSase velocity by G-6-P, we measured the velocity of GSase extracted under E and H conditions as a function of [G-6-P] under physiological concentrations of P i and ATP. The curve for the velocity of the enzyme extracted under E and H as a function of [G-6-P] is shown in Fig. 6 . The velocity in the in vivo range of [G-6-P] was determined from a linear regression. When the in vivo concentrations of G-6-P were used, the velocity for E at 0.22 mM G-6-P was found to be 14.6 mU ⅐ kg Ϫ1 min Ϫ1 and that for H at 0.40 mM G-6-P to be 26.1 mU ⅐ kg Ϫ1 min
Ϫ1
. The 1.8-fold change in in vitro velocity is significantly lower (P Ͻ 0.001, Z-test) than the 2.8 Ϯ 0.2-fold change in glycogen synthesis flux.
Calculation of responsivity. The responsivity of glycogen synthesis flux (J) to plasma glucose was calculated from Eq. 2 and the measured fractional change in glycogen synthesis and [glucose] plasma for each animal ( Table 1) . The values of R G 0 J for individual animals ranged from 0.88 to 1.13, with an average R G 0 J ϭ 1.1 Ϯ 0.03 (Table 1) . From this value and Eq. 6, the C GT/Hk J ϭ 1.1 Ϯ 0.03 for the GT/Hk step.
Calculation of elasticities to [G-6-P].
The elasticity of GSase to [G-6-P] was calculated from the measured changes in the velocity of GSase in the in vitro assay and Eq. A9 to be ⑀ G-6-P GSase ϭ 0.79. The in vivo elasticity of GSase to [G-6-P] was higher; ⑀ G-6-P GSase ϭ 1.9. The ⑀ G-6-P GT/Hk values were determined using Eq. 5 for a range of ratios of glycolysis to GT/Hk. For the range of ratios of 0.15 to 0.4, the ⑀ G-6-P GT/Hk ranged from Ϫ0.185 to Ϫ0.556. Ratios Ͻ0.15 yielded values of ⑀ G-6-P GT/Hk Ͼ0, which would correspond to activation of GT/Hk by product G-6-P.
Calculation of flux control coefficients from elasticities. From the calculated ⑀ G-6-P GT/Hk values and the in vivo ⑀ G-6-P GSase at each ratio of glycolytic and GT/Hk flux, the control coefficients for GT/Hk, GSase, and glycolysis were calculated (Table 3 .) The values were calculated for a glycolytic flux ranging from 0.15 to 0.4 times the flux through the GT/phosphorylation step. Throughout the range of glycolytic flux ratios, GT/Hk has the largest control coefficient for the glycogen synthesis flux, with a constant C GT/Hk at all ratios of J glycolysis /J GT/Hk .
DISCUSSION
Because of the coordinate increases in the activity of GT, Hk, and GSase with insulin, it has long been difficult to assess the flux-controlling step(s) in the muscle glycogen synthesis pathway. In this study, we applied MCA to determine quantitatively the contributions of GT/Hk, GSase, and glycolysis to the control of this pathway. The synthesis rate of muscle glycogen was measured at two glucose concentrations during a hyperinsulinemic clamp to alter GT activity. A flux control coefficient of C GT/Hk J ϭ 1.1 Ϯ 0.03 was calculated for the GT/Hk step from the responsivity to glucose and Eq. 6, which indicates that the rate of glycogen synthesis is approximately proportional to the total activity of this step. An independent measure of C GT/Hk J based on the elasticities and the Branch Point Theorem yielded values comparable to the direct measure ( Table 3 ). The measured in vitro and in vivo elasticity of GSase to G-6-P was high relative to the elasticity of GT/Hk measured in vivo, also indicative of minimal control by GSase over the muscle glycogen synthesis flux. Although glycolysis was not measured directly, it was shown not to affect the conclusion that GT/Hk is the major flux control point, whereas GSase exerts less control over the glycogen synthesis flux than does glycolysis. In the sections to follow, we discuss evidence Validation of the MCA model of muscle glycogen synthesis. The primary assumption in applying MCA to calculate flux control is that the activity of GT/Hk may be altered (through plasma glucose concentration) without affecting the activity of GSase other than through a change in the concentration of G-6-P. A change in G-6-P concentration is allowable, because it is internal to the portion of the glycogen synthesis pathway being modeled (13, 31) . The primary external effectors of GSase activity are ATP and P i , which were measured by 31 P NMR and found not to change between the E and H stages of the clamp. The constancy of ATP agrees with the findings in 31 P NMR studies of human muscle during hyperinsulinemia (26, 27) . In human studies, a small increase in [P i ] was measured during H relative to E under hyperinsulinemic conditions that was not observed in the rat muscle. The GSase activity may also be altered by phosphorylation. To assess whether this occurred, the GSase%I was measured and found to be the same under E and H conditions at the insulin level used in this study. This finding is in agreement with a previous study of human muscle (39) , which found that, under high plasma insulin, GSase%I is independent of plasma glucose concentration.
Effects of muscle glycolysis on the calculated control coefficients. To calculate a flux control coefficient for GSase, it was assumed that the muscle glycolytic flux is independent of plasma glucose concentration under hyperinsulinemic conditions. If this is the case, then the elasticity of glycolysis to G-6-P is negligible, and the control coefficient of GSase may be directly calculated from the relative elasticities of GT/Hk and glycolysis to G-6-P. The independence of muscle glycolysis to glucose concentration is supported by several studies that estimated the constancy of muscle glycolysis either from measurements of whole body glucose oxidation (27, 40) , for which muscle is the primary disposal pathway under hyperinsulinemic conditions, or from arteriovenous difference measurements across limbs (22) . Under almost identical conditions of plasma insulin and glucose as used in the present study, Farrace and Rossetti (11) measured no change in glycolysis with glucose concentration.
Because glycolysis was not directly measured, the flux control coefficients were calculated for a range of glycolytic fluxes from 0.15 to 0.4, the rate of the flux through the GT/Hk combined reactions. The minimal value of 0.15 was used because ⑀ G-6-P GT/Hk Յ 0 at ratios Ͻ0.145, which would indicate the improbable activation of Hk by product G-6-P. The maximum ratio of 0.5 was determined from the ratio of whole body glucose oxidation to whole body glucose uptake measured by Farrace and Rossetti (11) , providing a maximum estimate of muscle glycolysis under these conditions of hyperinsulinemia because it neglects other tissues oxidizing glucose, such as the brain. More recently, Jucker et al. (15) measured directly the rates of rat muscle glycolysis and glycogen synthesis under conditions of euglycemic and hyperglycemic hyperinsulinemia using 13 C NMR. They found that the muscle glycolysis flux did not change with plasma glucose level, which supports our assumption that the elasticity of glycolysis to G-6-P is close to 0. They measured a ratio for glycolysis of 0.3 to the total flux through GT/Hk under euglycemic conditions (15) . Over the entire range of ratios (see Table 3 ), it was found that the flux control coefficient of GT/Hk is the highest for the pathway, whereas control by GSase remains much smaller. At higher values of the ratio of glycolysis to total GT/Hk flux, the glycolytic pathway exerts significant flux control for glycogen synthesis. The physiological significance of a high negative control coefficient of glycolysis may be to allow the muscle to rapidly shunt glucose away from storage as glycogen when an increase in energy is needed. Because of the low elasticity of glycolysis and GT/Hk to G-6-P, an increase in the glycolytic rate to meet the energy requirements of the muscle would shunt glucose away from storage as glycogen in a near 1:1 ratio. In contrast to the situation in the rat muscle, the relative rate of muscle glycolysis to muscle glycogen synthesis under hyperinsulinemic conditions in the human is low (27, 31) , and this pathway will have a small flux control coefficient.
Comparison with other work. Several recent studies of muscle glycogen synthesis measured its rate at different plasma glucose concentrations under hyperinsulinemic conditions. We have calculated the flux control coefficient for GT/Hk from the results presented in these studies. The results of this calculation are shown in Table 4 (11, 21, 22, 26) . The values, ranging from 0.99 to 1.74, are consistent with the conclusion that GT/Hk exerts the majority of flux control in the muscle glycogen synthesis pathway. The values are generally greater than 1, which reflects the negative control coefficient of glycolysis. In the study of Jucker et al. (15) , the change in glycogen synthesis rate and G-6-P with glucose level was similar to the change in the present study, which implies that the majority of control is exerted at GT/Hk. The elasticities to G-6-P were estimated by inhibiting glycolysis with a free fatty acid (FFA) infusion, which led to a substantial decrease in total glucose uptake with only a small increase in G-6-P. From this result they concluded that the in vivo elasticity of GT/Hk is high (Ϫ2.18), and they reported that the C GT/Hk J ϭ 0.55 Ϯ 0.1 compared with a C GSase J ϭ 0.30 Ϯ 0.06. The discrepancy from our finding of a low elasticity of GT/Hk may be reconciled by the subsequent finding that the activity of glucose transport is reduced during FFA infusion (10) . In light of these findings, the reduction in total glucose uptake during FFA infusion was more likely due to a reduction in GT/Hk activity than a high elasticity of Hk, as proposed by the authors.
GT may exert the majority of flux control for the GT/Hk step. In the present analysis, the GT-and Hk-catalyzed reactions are treated as a single equivalent reaction, because the intracellular glucose concentration was not measured. The relative control exerted by the individual GT and Hk reactions may be determined from the intracellular glucose concentration. Several studies, including two recent 13 C NMR studies (5, 28) , have found that, under hyperinsulinemic conditions, intracellular muscle glucose is Ͻ1 mM, which is the precision of the measurement. The low concentration of intracellular glucose relative to plasma glucose and the high Michaelis-Menten constant of the transporters (ϳ20 mM glucose) (19) suggest that the glucose transport flux at euglycemia is insensitive to changes in intracellular glucose concentration. From this it may be concluded that transport is responsible for the major part of flux control. Studies that have found a correlation between unidirectional GT measured using nonmetabolizable glucose analogs and muscle glucose uptake (3, 6) are consistent with GT having a higher flux control coefficient than Hk.
Compartmentation. A complication in the calculation of the in vivo elasticities is the possibility of compartmentation of G-6-P leading to a different concentration in the environment of GSase than the whole tissue concentration measured by 31 P NMR. This compartmentation may be between different fiber types or within the microenvironment of individual muscle cells. There is no effect of compartmentation on the calculated flux control coefficient of GT/Hk from the measured responsivity. The elasticity used in this calculation (31) is a minimum value that is assumed on the basis of the enzymatic properties of the isolated GT and Hk (31) enzymes. Furthermore, the concentration of the modulated effector (extracellular glucose) is not effected by compartmentation. For GSase to have a high control coefficient, its elasticity to G-6-P would have to be at least an order of magnitude lower than the values measured in vivo and in vitro. On the basis of in vitro kinetics of the enzyme, such a low elasticity would only occur at saturating concentrations of G-6-P, which at the GSase%I ratio measured in vitro would only occur at G-6-P concentrations well over 1 mM (25) . This high local concentration is unlikely, because it defeats the ability to regulate the enzyme by phosphorylation, which alters the kinetics of GSase by shifting the G-6-P association constant of the enzyme.
The role of GSase in maintaining G-6-P homeostasis. The low flux control coefficient of GSase seems paradoxical, given the known increase in GSase activity with insulin concentration (7, 35, 39) . The GSase%I measured in the present study is consistent with previous measurements under similar conditions and well above the activity measured under basal insulin (21, 25 ). An explanation we have proposed for the function of the insulin-dependent regulation of GSase phosphorylation state is that it reduces the changes in G-6-P concentration required for the velocity of the enzyme to match the rate set by the GT/Hk steps. As shown by Roach and Larner (25) and others (23) , under in vivo concentrations of ATP, the velocity of GSase has a sigmoidal relationship to %I at fixed G-6-P concentrations. The region of maximum sensitivity to %I at the in vivo G-6-P concentration of 200-400 mol/kg is in the 30-40%I range achieved by insulin.
The high in vivo elasticity of GSase to G-6-P (Fig. 6 ) would further act to reduce the changes in G-6-P concentration needed to accommodate changes in GT/Hk velocity due to plasma glucose. A high elasticity to G-6-P was also measured in human muscle by use of 31 P NMR to measure G-6-P concentrations (26) . The high elasticity may be explained by the sigmoidal relationship between GSase velocity and G-6-P concentration under simulated in vivo conditions when GSase%I is Ͻ60% (25) . We found the slope of the in vitro GSase velocity vs. G-6-P curve to be greater than unity in the in vivo G-6-P range (Fig. 6) , which supports this explanation. However, within the accuracy of the in vivo measure of G-6-P concentration, other mechanisms cannot be ruled out.
Conclusions. Under hyperinsulinemic conditions, the combined reactions of GT and Hk primarily determine the rate of muscle glycogen synthesis in the rat. The use of different plasma glucose levels to modulate GT/Hk activity allows MCA to be applied to the pathway, because effectors external to the glycogen synthe- sis pathway, such as ATP and the activity of GSase%I, were not affected by the glucose level. The low control coefficient of GSase is consistent with our previous proposal that the role of insulin stimulation of GSase dephosphorylation is for maintaining G-6-P homeostasis rather than controlling the flux (31) . Because of the enhanced rate of glycolysis in rat muscle relative to human muscle, there may be a significant role for glycolysis in the control of the rate of glycogen synthesis. However, the primary control of the rate of muscle glycogen synthesis is exerted by the combined reactions of GT and Hk.
APPENDIX
In the MCA model of the glycogen synthesis pathway (30), the pathway is simplified into a two-step reaction. The combined reactions of GT and Hk convert extracellular glucose to G-6-P. Subsequently, G-6-P is converted by the combined reactions of glucose phosphate isomerase, UDP-glucose transferase, and glycogen synthase to glycogen. Because GSase is the only enzyme in the proximal reactions that changes activity with insulin, this series of reactions is referred to as GSase. The combination of sequential reaction steps into a single equivalent reaction has been shown to be valid, provided that substrates within a grouped series of reactions do not act as effectors outside of the group (13) . For the muscle glycogen synthesis pathway, G-6-P is the only substrate that effects the activity of both the GT/Hk and GSase group of enzymes (38) and is therefore treated explicitly in the model.
The most direct method for determining the flux control coefficients of the enzymes in the glycogen synthesis pathway would be to vary the activity of each enzyme individually and to measure the resultant change in glycogen synthesis flux. For the case of muscle glycogen synthesis, it is not possible to directly alter the activity of GT/Hk without affecting the activity of GSase because of the coordinated regulation of these enzymes. In MCA, several methods have been developed to calculate flux control coefficients by modulating the in vivo velocity of an enzyme through variation of the concentration of either substrates or allosteric effectors. In this APPENDIX we describe the application of MCA to determine C GT/Hk
from the Measured Elasticities to G-6-P and the Branch Point Theorem
The relative control of GT/Hk and GSase was determined from the sensitivity of the velocity of these reactions to the change in G-6-P concentration. This sensitivity, termed "elasticity" (⑀ Z V ), is defined as the fractional change in enzyme velocity (V) for a fractional change in the level of an effector, Z
This relationship is valid at the in vivo substrate and effector levels. The value may be quantitated in vivo, or in vitro if assayed in the presence of all effectors at their in vivo levels. On the basis of the connectivity theorem of MCA (16), the control coefficients for GT/Hk and GSase and glycolysis are related by the elasticities of these pathways to G-6-P:
strate, plasma glucose. Writing the velocity of the GT/Hk step as a total differential in G o and G-6-P gives ␦J GT/HK /J GT/HK-E ϭ ⑀ G 0 GT/Hk ͑␦G 0 /G 0E ͒ ϩ ⑀ G-6-P GT/Hk ͑␦G-6-P/G-6-P E ͒ (A12)
Because the GT/Hk reaction feeds both glycogen synthesis and glycolysis, the flux JЈ is the sum of these pathways. Equation A12 may be solved for ⑀ G-6-P GT/Hk , yielding ⑀ G-6-P GT/Hk ϭ ͑␦JЈ/J E Ϫ ⑀ G 0
